Home | All results_reference

[RDF data]
Results Reference #1231

Resource URI: http://static.linkedct.org/resource/results_reference/1231
linkedct:citation Moore MJ, Goldstein D, Hamm J, et al.: Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]. [Abstract] J Clin Oncol 23 (Suppl 16): A-1, 1s, 2005.
rdfs:label Results Reference #1231
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00026338>
linkedct:results_reference_id 1231 (xsd:int)
rdf:type linkedct:results_reference